Solid Malignancies clinical trials

Explore recruiting solid malignancies clinical trials.

Recruiting solid malignancies studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular Therapies

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1/2a, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Malignancies

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase 1 open label trial of MST-0312 alone and in combination in subjects with solid malignancies

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination with Anticancer Treatments in Patients with Solid Malignancies

Spain, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An Open-label Study to check Safety, Tolerability and medication behaviour of a capsule with AZD6244 in Patients with Advanced Solid Malignancies

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors

Bulgaria, Romania

Human Pharmacology (Phase I)- Other EU CTIS Study details

Solid Malignancies trials by city

Solid Malignancies in Toronto Solid Malignancies in Vancouver Solid Malignancies in Montreal Solid Malignancies in Calgary Solid Malignancies in Edmonton Solid Malignancies in Ottawa Solid Malignancies in Winnipeg Solid Malignancies in Quebec City Solid Malignancies in Hamilton Solid Malignancies in Kitchener Solid Malignancies in London Solid Malignancies in Halifax Solid Malignancies in New York Solid Malignancies in Los Angeles Solid Malignancies in Chicago Solid Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease